Concepedia

Vance W. Berger

VW

40

Publications

1.7K

Citations

23

H-Index

1997

Active since

Affiliations

National Cancer Institute(Current)

University of Maryland, Baltimore County

Center for Biologics Evaluation and Research

University of North Carolina at Chapel Hill

United States Food and Drug Administration

Vance W. Berger is an author at National Cancer Institute specializing in medicine, statistics, and biostatistics.

Top concepts

StatisticsMedicineBiostatisticsClinical TrialsStatistical InferenceClinical Trial DesignHealthBiasEngineeringPatient Selection

Publications per year

1997–2021

40

Publications

40

Minimizing predictability while retaining balance through the use of less restrictive randomization procedures

Vance W. Berger, Anastasia Ivanova, Maria Deloria Knoll · Statistics in Medicine · 2003 · 194 citations

Restrictive Randomization Procedures, Patient Selection, Cancer Management +23

Pros and cons of permutation tests in clinical trials

Vance W. Berger · Statistics in Medicine · 2000 · 164 citations

Detecting Selection Bias in Randomized Clinical Trials

Vance W. Berger, Derek V. Exner · Controlled Clinical Trials · 1999 · 162 citations

Clinical Trial Design, Selection Bias, Clinical Trial Management +9

Quantifying the Magnitude of Baseline Covariate Imbalances Resulting from Selection Bias in Randomized Clinical Trials

Vance W. Berger · Biometrical Journal · 2005 · 114 citations

Behavioral Decision Making, Patient Selection, Clinical Endpoint +24

A roadmap to using randomization in clinical trials

Vance W. Berger, Louis Bour, Kerstine Carter et al. · BMC Medical Research Methodology · 2021 · 110 citations · Full text

Rows per page

1–5 of 40